Open Access

This article has an erratum: [https://doi.org/10.1051/mbcb/2023015]


Fig. 11

image

Download original image

A chart shows WBCs count results (mean ± standard deviation) of subgroups treated for 2 weeks with either Nigella Sativa (NS) or (–)-epigallocatechin-3-gallate (EGCG) then, with 7,12-dimethylbenza[a]anthracene (DMBA) combined with either NS (Aiii) or EGCG (Ciii) for 6 weeks as compared to each other and to healthy untreated group (G I). MID: Less frequently occurring cells such as monocytes, eosinophils, basophils and other precursor white cells. ab Indicate that a significant difference (P value < 0.05) exists between compared sub/groups that are marked with the same letter.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.